NCT02623166 Treatment of Pneumonia, Diarrhoea and Fever in Children by Community Health Workers Status COMPLETED Phase N/A
NCT02598089 Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) Status COMPLETED Phase PHASE1
NCT02590627 In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure Status COMPLETED Phase PHASE4
NCT02589782 Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s) Status COMPLETED Phase PHASE2/PHASE3
NCT02585700 A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine Status COMPLETED Phase PHASE1
NCT02480101 Reactogenicity, Safety and Immunogenicity of a LAIV H7N9 Influenza Vaccine Status COMPLETED Phase PHASE1
NCT02353494 Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria Status COMPLETED Phase N/A
NCT02344628 Comparison of Two Different Doses of Azithromycin for Treatment of Yaws Status COMPLETED Phase PHASE3
NCT02342171 Emergency Evaluation of Convalescent Plasma for Ebola Viral Disease (EVD) in Guinea Status COMPLETED Phase PHASE2/PHASE3
NCT02296983 A Study to Find Out if the New Ebola Vaccine is Safe and Stimulates Immunity That Might Protect Adults in Kilifi, Kenya. Status UNKNOWN Phase PHASE1
NCT02289027 A Clinical Trial on the Candidate Vaccine cAd3-EBOZ in Healthy Adults in Switzerland Status COMPLETED Phase PHASE1/PHASE2
NCT02283099 Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP) Status COMPLETED Phase PHASE1
NCT02229357 Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine Status COMPLETED Phase PHASE2
NCT02216734 Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe Status UNKNOWN Phase NA